Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.47 |
| ▸ | BACE1 | P56817 | 10/20 | 0.46 |
| ▸ | CTSD | P07339 | 10/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5223382 | 1.00 | BCHE (0.47) | BCHEBACE1CTSDMEN1KMT2A | |
| SCHEMBL5226080 | 0.86 | BCHE (0.47) | BCHEBACE1CTSDMEN1KMT2A | |
| SCHEMBL5226085 | 0.86 | BCHE (0.47) | BCHEBACE1CTSDMEN1KMT2A | |
| SCHEMBL5314169 | 0.85 | BCHE (0.45) | BCHEBACE1CTSDMEN1KMT2A | |
| SCHEMBL5314172 | 0.85 | BCHE (0.45) | BCHEBACE1CTSDMEN1KMT2A | |
| SCHEMBL5218538 | 0.84 | BCHE (0.47) | BCHEBACE1CTSDMEN1KMT2A | |
| SCHEMBL5218547 | 0.84 | BCHE (0.47) | BCHEBACE1CTSDMEN1KMT2A | |
| SCHEMBL5219994 | 0.84 | BACE1 (0.55) | BACE1CTSD | |
| SCHEMBL5219985 | 0.84 | BACE1 (0.55) | BACE1CTSD | |
| SCHEMBL5219988 | 0.84 | BACE1 (0.50) | BCHEBACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567488-B1 | HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | GLAXO GROUP LTD (GB) | 2007-02-21 | — | — | EP | disclosed |